Michele Hooper - UnitedHealth Group Independent Director

UNH Stock  EUR 465.30  11.85  2.61%   

Director

Ms. Michele J. Hooper is Independent Director of the Company. Ms. Hooper is President and CEO of The Directors Council, a private company she cofounded in 2003 that works with corporate boards to increase their independence, effectiveness and diversity. She was President and CEO of Voyager Expanded Learning, a developer and provider of learning programs and teacher training for public schools, from 1999 until 2000. Prior to that, she was President and CEO of Stadtlander Drug Company, Inc., a provider of diseasespecific pharmaceutical care, from 1998 until Stadtlander was acquired in 1999. Ms. Hooper is a nationally recognized corporate governance expert. Ms. Hooper currently serves as a director of PPG Industries, Inc. and United Airlines, Inc. since 2007.
Age 67
Tenure 17 years
Phone952 936 1300
Webhttps://www.unitedhealthgroup.com

UnitedHealth Group Management Efficiency

The company has return on total asset (ROA) of 0.0776 % which means that it generated a profit of $0.0776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2535 %, meaning that it generated $0.2535 on every $100 dollars invested by stockholders. UnitedHealth Group's management efficiency ratios could be used to measure how well UnitedHealth Group manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 54.51 B in total debt with debt to equity ratio (D/E) of 0.66, which is about average as compared to similar companies. UnitedHealth Group has a current ratio of 0.7, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist UnitedHealth Group until it has trouble settling it off, either with new capital or with free cash flow. So, UnitedHealth Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like UnitedHealth Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for UnitedHealth to invest in growth at high rates of return. When we think about UnitedHealth Group's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Michael KregerNorAm Drilling AS
33
Randall FindlaySuperior Plus Corp
67
Robert EngbloomSuperior Plus Corp
64
Peter KernNorAm Drilling AS
50
Douglas HarrisonSuperior Plus Corp
58
David SmithSuperior Plus Corp
59
Richard BradeenSuperior Plus Corp
61
Patrick GottschalkSuperior Plus Corp
54
Ross LevinsohnNorAm Drilling AS
54
James ArestiaNorAm Drilling AS
N/A
Walentin MiroshSuperior Plus Corp
71
Craig JacobsonNorAm Drilling AS
65
Catherine BestSuperior Plus Corp
64
Laura WalkerNorAm Drilling AS
60
Mary JordanSuperior Plus Corp
58
Peter MurphyNorAm Drilling AS
55
Eugene BissellSuperior Plus Corp
64
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota. UNITEDHEALTH GROUP operates under Healthcare Plans classification in Germany and is traded on Frankfurt Stock Exchange. It employs 330000 people. UnitedHealth Group Incorporated (UNH) is traded on Frankfurt Exchange in Germany and employs 34 people.

Management Performance

UnitedHealth Group Leadership Team

Elected by the shareholders, the UnitedHealth Group's board of directors comprises two types of representatives: UnitedHealth Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UnitedHealth. The board's role is to monitor UnitedHealth Group's management team and ensure that shareholders' interests are well served. UnitedHealth Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UnitedHealth Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
Gail Wilensky, Independent Director
Richard Burke, Independent Chairman of the Board
Valerie Rice, Independent Director
Andrew Witty, President, Chief Executive Officer of Optum
Sir Witty, CEO Director
Stephen Hemsley, Non-Executive Chairman of the Board
John Rex, Chief Financial Officer, Executive Vice President
Dirk McMahon, Chief Executive Officer - UnitedHealthcare
DEllen Wilson, Executive Vice President - Human Capital
Steven Nelson, Executive Vice President CEO of UnitedHealthcare
Zachary Sopcak, VP Relations
William McNabb, Independent Director
John Noseworthy, Independent Director
Larry Renfro, Executive Vice President CEO - Optum
Robert Darretta, Independent Director
Jennifer Smoter, VP Officer
William Ballard, Independent Director
Glenn Renwick, Independent Director
Rupert Bondy, Ex Officer
Sandeep Dadlani, Ex Officer
Michele Hooper, Independent Director
Timothy Flynn, Independent Director
Thomas Roos, Senior Vice President, Chief Accounting Officer
Rodger Lawson, Independent Director
Frances Jacobs, IR Contact Officer
Matthew Friedrich, Executive Vice President Chief Legal Officer
Kenneth Shine, Independent Director
Edson Bueno, Director
D Wilson, Executive Vice President - Human Capital
F McNabb, Independent Director
Marianne Short, Executive Vice President Chief Legal Officer
David Wichmann, CFO, Executive Vice President and Presidentident - UnitedHealth Group Operations
Brian Thompson, Ex UnitedHealthcare
James Barry, Director Pennsylvania

UnitedHealth Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UnitedHealth Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards UnitedHealth Group in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, UnitedHealth Group's short interest history, or implied volatility extrapolated from UnitedHealth Group options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for UnitedHealth Stock analysis

When running UnitedHealth Group's price analysis, check to measure UnitedHealth Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UnitedHealth Group is operating at the current time. Most of UnitedHealth Group's value examination focuses on studying past and present price action to predict the probability of UnitedHealth Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UnitedHealth Group's price. Additionally, you may evaluate how the addition of UnitedHealth Group to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Transaction History
View history of all your transactions and understand their impact on performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.